GlaxoSmithKline says its COVID-19 antibody drug appears to be effective against the omicron variant based on initial laboratory testing
GlaxoSmithKline says its COVID-19 antibody drug appears to be effective against the omicron variant based on initial laboratory testing
Please to comment